Literature DB >> 20943967

The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults.

Long Truong Hoang1, David J Lynn, Matt Henn, Bruce W Birren, Niall J Lennon, Phuong Thi Le, Kien Thi Hue Duong, Tham Thi Hong Nguyen, Lanh Ngoc Mai, Jeremy J Farrar, Martin L Hibberd, Cameron P Simmons.   

Abstract

Dengue is a pantropic public health problem. In children, dengue shock syndrome (DSS) is the most common life-threatening complication. The ability to predict which patients may develop DSS may improve triage and treatment. To this end, we conducted a nested case-control comparison of the early host transcriptional features in 24 DSS patients and 56 sex-, age-, and virus serotype-matched uncomplicated (UC) dengue patients. In the first instance, we defined the "early dengue" profile. The transcriptional signature in acute rather than convalescent samples (≤72 h post-illness onset) was defined by an overabundance of interferon-inducible transcripts (31% of the 551 overabundant transcripts) and canonical gene ontology terms that included the following: response to virus, immune response, innate immune response, and inflammatory response. Pathway and network analyses identified STAT1, STAT2, STAT3, IRF7, IRF9, IRF1, CEBPB, and SP1 as key transcriptional factors mediating the early response. Strikingly, the only difference in the transcriptional signatures of early DSS and UC dengue cases was the greater abundance of several neutrophil-associated transcripts in patients who progressed to DSS, a finding supported by higher plasma concentrations of several canonical proteins associated with neutrophil degranulation (bactericidal/permeability-increasing protein [BPI], elastase 2 [ELA2], and defensin 1 alpha [DEF1A]). Elevated levels of neutrophil-associated transcripts were independent of the neutrophil count and also of the genotype of the infecting virus, as genome-length sequences of dengue virus serotype 1 (DENV-1) (n = 15) and DENV-2 (n = 3) sampled from DSS patients were phylogenetically indistinguishable from those sampled from uncomplicated dengue patients (32 DENV-1 and 9 DENV-2 sequences). Collectively, these data suggest a hitherto unrecognized association between neutrophil activation, pathogenesis, and the development of DSS and point to future strategies for guiding prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943967      PMCID: PMC3004338          DOI: 10.1128/JVI.01224-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Selection for virulent dengue viruses occurs in humans and mosquitoes.

Authors:  Raymond Cologna; Philip M Armstrong; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

4.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

5.  Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever.

Authors:  D B Bethell; K Flobbe; X T Cao; N P Day; T P Pham; W A Buurman; M J Cardosa; N J White; D Kwiatkowski
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

6.  Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration.

Authors:  Bastien Hermant; Stephanie Bibert; Evelyne Concord; Bernard Dublet; Marianne Weidenhaupt; Thierry Vernet; Danielle Gulino-Debrac
Journal:  J Biol Chem       Date:  2003-02-12       Impact factor: 5.157

7.  Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever.

Authors:  D B Bethell; J Gamble; P L Pham; M D Nguyen; T H Tran; T H Ha; T N Tran; T H Dong; I B Gartside; N J White; N P Day
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

8.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

9.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

10.  Emergence and global spread of a dengue serotype 3, subtype III virus.

Authors:  William B Messer; Duane J Gubler; Eva Harris; Kamalanayani Sivananthan; Aravinda M de Silva
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more
  61 in total

Review 1.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 2.  Revealing the molecular signatures of host-pathogen interactions.

Authors:  Chiea-Chuen Khor; Martin L Hibberd
Journal:  Genome Biol       Date:  2011-10-19       Impact factor: 13.583

Review 3.  Transcriptomic immune profiles of human flavivirus-specific T-cell responses.

Authors:  Alba Grifoni; Yuan Tian; Alessandro Sette; Daniela Weiskopf
Journal:  Immunology       Date:  2020-01-07       Impact factor: 7.397

4.  Critical role of Dengue Virus NS1 protein in viral replication.

Authors:  Jingjing Fan; Yi Liu; Zhiming Yuan
Journal:  Virol Sin       Date:  2014-05-26       Impact factor: 4.327

Review 5.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

6.  Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.

Authors:  Marcin Kwissa; Helder I Nakaya; Nattawat Onlamoon; Jens Wrammert; Francois Villinger; Guey Chuen Perng; Sutee Yoksan; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Rafi Ahmed; Bali Pulendran
Journal:  Cell Host Microbe       Date:  2014-06-26       Impact factor: 21.023

7.  Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma.

Authors:  Kien Duong Thi Hue; Trung Vu Tuan; Hanh Tien Nguyen Thi; Chau Tran Nguyen Bich; Huy Huynh Le Anh; Bridget A Wills; Cameron P Simmons
Journal:  J Virol Methods       Date:  2011-08-05       Impact factor: 2.014

8.  Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.

Authors:  Penny A Rudd; Jane Wilson; Joy Gardner; Thibaut Larcher; Candice Babarit; Thuy T Le; Itaru Anraku; Yutaro Kumagai; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Alexander A Khromykh; Andreas Suhrbier
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

9.  DHIM supporting immunologic investigations and the identification of immune correlates of protection.

Authors:  Alan L Rothman
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

10.  Severe neutropenia in dengue patients: prevalence and significance.

Authors:  Tun-Linn Thein; David C Lye; Yee-Sin Leo; Joshua G X Wong; Ying Hao; Annelies Wilder-Smith
Journal:  Am J Trop Med Hyg       Date:  2014-04-14       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.